---
title: "UBS' Investment Ratings and TPs on CRO Stocks (Table)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292579364.md"
description: "UBS published a research report providing investment ratings and target prices for several CRO stocks. The report lists 'Buy' ratings with specific target price adjustments for Wuxi AppTec, Wuxi Bio, Wuxi XDC, Pharmaron, and Tigermed, alongside current short selling data as of July 14, 2026."
datetime: "2026-07-14T07:00:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292579364.md)
  - [en](https://longbridge.com/en/news/292579364.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292579364.md)
generator: "portal-rs"
---

# UBS' Investment Ratings and TPs on CRO Stocks (Table)

UBS published a research report listing the investment ratings and target prices for CRO stocks as follows:

Stock | Investment Rating | TP (HKD)

WUXI APPTEC (02359.HK) +8.000 (+5.277%) Short selling $166.59M; Ratio 32.332% | Buy | HKD171.2 -> HKD176.5

WUXI BIO (02269.HK) +1.140 (+3.055%) Short selling $94.37M; Ratio 16.551% | Buy | HKD51.1

WUXI XDC (02268.HK) +1.250 (+2.176%) Short selling $30.47M; Ratio 18.993% | Buy | HKD89.4 -> HKD87.4

PHARMARON (03759.HK) +1.400 (+6.306%) Short selling $24.28M; Ratio 7.613% | Buy | HKD30 -> HKD31.8

TIGERMED (03347.HK) +1.300 (+3.583%) Short selling $10.61M; Ratio 31.294% | Buy | HKD52 -> HKD51.3

(gc/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-07-14 12:25.)

### Related Stocks

- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [02268.HK](https://longbridge.com/en/quote/02268.HK.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [WXXWY.US](https://longbridge.com/en/quote/WXXWY.US.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [02269.HK](https://longbridge.com/en/quote/02269.HK.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Pharmaron Beijing announces extraordinary general meeting, H share class meeting](https://longbridge.com/en/news/296918409.md)
- [WuXi AppTec says cyberattack hits DEL platform data, operations unaffected](https://longbridge.com/en/news/296804345.md)
- [WUXI APPTEC  Biology Business DEL Platform Experiences Cybersecurity Incident](https://longbridge.com/en/news/296820305.md)
- [WuXi XDC Cayman: Revenue and profit surged over 37% YoY, with robust backlog and global expansion fueling growth](https://longbridge.com/en/news/296798332.md)
- [WuXi XDC grants 342,300 restricted shares to employees under 2024 share scheme](https://longbridge.com/en/news/296925871.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**